Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

dabur india limited - sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o) - sodium monofluorophosphate 7.6 mg in 1 g - anticavity regular brushing with fluoride toothpaste helps protect teeth and roots against cavities

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

level oral care, llc - sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o) - sodium monofluorophosphate 76 g in 100 g - uses: aids in the prevention of dental cavities.

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

colgate-palmolive canada - sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o) - sodium monofluorophosphate 7.6 mg in 1 g - anticavity helps protect against cavities

Turcija - turku - TİTCK (Türkİye İlaç Ve Tibbİ Cİhaz Kurumu)

bİem İlaÇ san. ve tİc. a.Ş. - fluorometholone - fluorometholone

Vācija - vācu - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

ursapharm arzneimittel gmbh (3091196) - fluorometholon - augentropfen - teil 1 - augentropfen; fluorometholon (07373) 1 milligramm

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

alcon laboratories, inc. - brinzolamide (unii: 9451z89515) (brinzolamide - unii:9451z89515), brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte) - brinzolamide 10 mg in 1 ml - simbrinza (brinzolamide/brimonidine tartrate ophthalmic suspension) 1%/0.2% is a fixed combination of a carbonic anhydrase inhibitor and an alpha 2 adrenergic receptor agonist indicated for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension. simbrinza is contraindicated in patients who are hypersensitive to any component of this product. simbrinza is contraindicated in neonates and infants (under the age of two years) [see use in specific populations (8.4)]. developmental toxicity studies with brinzolamide in rabbits at oral doses of 1, 3, and 6 mg/kg/day (20, 60, and 120 times the recommended human ophthalmic dose) produced maternal toxicity at 6 mg/kg/day and a significant increase in the number of fetal variations, such as accessory skull bones, which was only slightly higher than the historic value at 1 and 6 mg/kg. in rats, statistically decreased body weights of fetuses from dams receiving oral doses of 18 mg/kg/day (180 times the recommended

Vācija - vācu - BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)

abz-pharma gmbh - geschäftsanschrift - (4238075) - amoxicillin-trihydrat - pulver zur herstellung einer suspension zum einnehmen - teil 1 - pulver zur herstellung einer suspension zum einnehmen; amoxicillin-trihydrat (13209) 286,9 milligramm

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

glaxosmithkline ag - amoxicillinum anhydricum, säure clavulanicum - pulver zur herstellung einer suspension zum einnehmen - amoxicillinum anhydricum 250 mg bestellen amoxicillinum trihydricum, säure clavulanicum laden von 62,5 mg, kalii clavulanas, arom.: vanillinum und andere aspartamum, excipiens staub endwerte. aussetzung reconstituta 5 ml. - infektionskrankheiten - synthetika

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - amoxicillinum anhydricum - granulat zur herstellung einer suspension zum einnehmen - amoxicillinum anhydricum 100 mg bestellen amoxicillinum trihydricum, arom.: bergamottae aetheroleum, vanillinum und andere aspartamum, conserv.: e 211, excipiens ad granulatum endwerte. aussetzung reconstituta 4 ml. - infektionskrankheiten - synthetika

Šveice - vācu - Swissmedic (Swiss Agency for Therapeutic Products)

sandoz pharmaceuticals ag - amoxicillinum anhydricum - granulat zur herstellung einer suspension zum einnehmen - amoxicillinum anhydricum 200 mg bis amoxicillinum trihydricum, arom.: bergamottae aetheroleum, vanillinum und andere aspartamum, conserv.: e 211, excipiens ad granulatum endwerte. aussetzung reconstituta 4 ml. - infektionskrankheiten - synthetika